πŸ‡ΊπŸ‡Έ FDA
Patent

US 7306787

Engineered particles and methods of use

granted A61KA61K31/685A61K9/0073

Quick answer

US patent 7306787 (Engineered particles and methods of use) held by Nektar Therapeutics expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
57
CPC classes
A61K, A61K31/685, A61K9/0073, A61K9/0075, A61K9/0078